- Home
- LEG vs SYRE Comparison
LEG vs SYRE Comparison
Compare LEG & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEG
- SYRE
- Stock Information
- Founded
- LEG 1883
- SYRE 2013
- Country
- LEG United States
- SYRE United States
- Employees
- LEG N/A
- SYRE N/A
- Industry
- LEG Home Furnishings
- SYRE Biotechnology: Pharmaceutical Preparations
- Sector
- LEG Consumer Discretionary
- SYRE Health Care
- Exchange
- LEG Nasdaq
- SYRE Nasdaq
- Market Cap
- LEG 1.2B
- SYRE 1.1B
- IPO Year
- LEG N/A
- SYRE 2016
- Fundamental
- Price
- LEG $9.03
- SYRE $23.71
- Analyst Decision
- LEG Hold
- SYRE Strong Buy
- Analyst Count
- LEG 4
- SYRE 5
- Target Price
- LEG $10.00
- SYRE $55.75
- AVG Volume (30 Days)
- LEG 1.8M
- SYRE 741.8K
- Earning Date
- LEG 10-27-2025
- SYRE 11-04-2025
- Dividend Yield
- LEG 2.22%
- SYRE N/A
- EPS Growth
- LEG N/A
- SYRE N/A
- EPS
- LEG 1.61
- SYRE N/A
- Revenue
- LEG $4,172,899,999.00
- SYRE N/A
- Revenue This Year
- LEG N/A
- SYRE N/A
- Revenue Next Year
- LEG N/A
- SYRE N/A
- P/E Ratio
- LEG $5.59
- SYRE N/A
- Revenue Growth
- LEG N/A
- SYRE N/A
- 52 Week Low
- LEG $6.48
- SYRE $10.91
- 52 Week High
- LEG $13.20
- SYRE $33.47
- Technical
- Relative Strength Index (RSI)
- LEG 48.62
- SYRE 60.31
- Support Level
- LEG $8.57
- SYRE $21.63
- Resistance Level
- LEG $9.25
- SYRE $24.19
- Average True Range (ATR)
- LEG 0.37
- SYRE 1.33
- MACD
- LEG -0.02
- SYRE -0.26
- Stochastic Oscillator
- LEG 20.14
- SYRE 67.01
About LEG Leggett & Platt Incorporated
Leggett & Platt Inc designs and produces engineered components and products found in homes and automobiles. It operates its business through three segments namely Bedding Products, Specialized Products, and Furniture, Flooring, and Textile Products. It generates the majority of its revenue from Bedding Products. Serving a broad suite of customers around the world, Leggett & Platt's products include bedding components, automotive seat support, and lumbar systems, specialty bedding foam and private label finished mattresses, components for home furniture, and work furniture, flooring underlayment, adjustable beds, and various other products.
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.